मेटाबॉलिक थेरपीसह स्तनाच्या कर्करोगासाठी परिवर्तनीय उपाय | खारघर, नवी मुंबई, महाराष्ट्र, भारत
स्तनाच्या कर्करोगाविरूद्धच्या लढाईत चयापचय थेरपीच्या परिवर्तनीय शक्तींचा उपयोग करा. अत्याधुनिक संशोधन आणि बरे होण्याच्या अविचल उत्साहाने भरलेले आशेचे नवीन क्षेत्र शोधा. कर्करोगाच्या पेशींवर विजय मिळवण्यासाठी तयार केलेल्या पायनियरिंग उपचारांसह चैतन्य स्वीकारा.
आर्ट ऑफ हीलिंग कॅन्सर येथे ब्रेस्ट कॅन्सरसाठी प्रिसिजन ऑन्कोलॉजी आणि मेटाबॉलिक थेरपीचे अनावरण
आर्ट ऑफ हीलिंग कॅन्सरमध्ये अचूक काळजी घेण्याच्या अतुलनीय उत्साहाचा अनुभव घ्या, जिथे आम्ही नवनवीन चयापचय थेरपीद्वारे स्तनाच्या कर्करोगाच्या उपचारांची पुन्हा व्याख्या करतो. आमचा सर्वांगीण दृष्टीकोन प्रत्येक व्यक्तीला त्यांच्या उपचारांच्या प्रवासात सक्षम करण्यासाठी दयाळू समर्थनासह अत्याधुनिक वैद्यकीय प्रगतीचे मिश्रण करतो. वैयक्तिक उपचारांवर आणि अनुरूप समाधानांवर लक्ष केंद्रित करून, आम्ही प्रत्येक रुग्णाच्या अद्वितीय गरजा पूर्ण करणारे लक्ष्यित हस्तक्षेप प्रदान करण्याचा प्रयत्न करतो. आशा आत्मसात करा आणि आर्ट ऑफ हीलिंग कॅन्सर येथे तुमच्या पाठीशी असलेल्या आमच्या समर्पित टीमसह स्तनाच्या कर्करोगाविरुद्धच्या तुमच्या लढ्यात शक्यतांचे एक नवीन क्षेत्र शोधा - जिथे प्रगत विज्ञान अतूट करुणा पूर्ण करते.
चैतन्य आत्मसात करा: स्तनाच्या कर्करोगाच्या उपचारात मेटाबॉलिक थेरपीच्या सामर्थ्याचे अनावरण
आमच्या अत्याधुनिक चयापचय थेरपीच्या दृष्टीकोनातून स्तनाच्या कर्करोगाच्या उपचारात बदल घडवून आणण्याचा अनुभव घ्या. आमची नाविन्यपूर्ण रणनीती निरोगी ऊतींना इजा न करता कर्करोगाच्या पेशींना लक्ष्य करते, स्तनाच्या कर्करोगाने प्रभावित झालेल्यांना आशा आणि उपचार देतात. इष्टतम परिणामकारकता आणि सुधारित परिणामांसाठी डिझाइन केलेल्या आमच्या वैयक्तिक उपचारांसह अचूक औषधाच्या नवीन युगाचा स्वीकार करा.
WHY CHOOSE ART OF HEALING CANCER
Blending traditional and modern treatments, we offer a holistic approach to cancer care.
Through chemosensitivity planning, we customize chemotherapy to each patient’s unique needs.
Precision and improved outcomes are hallmarks of our state-of-the-art robotic surgery techniques.
Utilizing genomic and transcriptomic data analysis, we provide the most advanced targeted therapy options.
As the only institution in India combining genomic and transcriptomic data with natural and herbal treatments, we offer comprehensive care.
We offer the most advanced immunotherapy treatments, including tailored vaccines and sensitivity testing to immunotherapy drugs.
One of the only centres trained on exploiting tumor Metabolism
दयाळू तज्ञांद्वारे स्तनाच्या कर्करोगाच्या व्यवस्थापनात डायनॅमिक प्रभुत्व.
आमच्या आदरणीय डॉक्टरांच्या टीममध्ये, पारंपारिक उपचारांच्या पलीकडे कौशल्याचा विस्तार आहे. ब्रेस्ट कॅन्सरच्या रूग्णांसाठी अचूक ऑन्कोलॉजी आणि एकात्मिक उपचारांमध्ये विशेष, आम्ही वैयक्तिक काळजी घेण्यास प्राधान्य देतो ज्यामध्ये प्रत्येक अद्वितीय केससाठी तयार केलेल्या चयापचय उपचार पद्धतींचा समावेश होतो. आमची बांधिलकी या आजाराशी लढा देणाऱ्यांच्या विविध गरजा पूर्ण करणारे सर्वसमावेशक उपाय ऑफर करण्यात आहे.
DR. MANDEEP SINGH MALHOTRA
- Mandeep Singh Malhotra; Surgical and Molecular Oncologist is the Chief Mentor at Art of Healing Cancer, with over 20 years of clinical oncology experience.
- Trained in surgical oncology at All India Institute of Medical Sciences, Delhi, and gained international experience in the UK, USA, and Europe.
- Experienced Robotic Surgeon, he is one of the pioneers for Robot Assisted Functional Breast Preservation.
- Molecular Oncology Certification from RGCC College Europe
- Expert in Advanced and Recurrent Cancer Treatment, utilizing Precision Oncology Techniques such as NGS, Transcriptomics, Tumor Vialbility assays and mapping them to plan Chemotherapy, Immunotherapy and Traditional / Off label medicine & Metabolic Therapy
DR. MOHIT SAXENA
- Senior Consultant in Medical Oncology with over 10 years of experience at Marengo Asia Hospitals, Gurugram.
- Holds MBBS and MD degrees from Sawai Man Singh Medical College, Jaipur; specialized in Medical Oncology from Gujarat Cancer & Research Institute, Ahmedabad.
- Expert in immunotherapy, various chemotherapy techniques (intravenous, intrathecal, oral), targeted therapy, precision medicine, and hormone therapy.
- Skilled in treating cancers of the head & neck, breast, lung, GI tract, hepatobiliary system, and genitourinary organs.
- Published multiple papers in respected national and international journals on cancer research.
- Previous roles include Artemis Hospital and C.K. Birla Hospital, highlighting extensive clinical experience.
- Known for research in hematological malignancies and advanced cancer treatment methods.
DR. SIDDHARTH SAHAI
- He is a medical Oncologist with 11+ years of experience.
- Siddharth has done MBBS from Maulana Azad Medical College, MD from Lady Harding Medical College, DM in Medical Oncology from AIIMS, New Delhi.
- Cleared ESMO Certification in 2013; trained in chemotherapy, immunotherapy, targeted therapy, and comprehensive oncology care.
- Focuses on solid tumors including head & neck, thoracic, breast, GI tract, hepatic, genitourinary malignancies, sarcomas, and brain tumors.
- Active member of ASCO, ESMO, SOMOI, ISMO.
- Worked at Venkateshwar Hospital, FMRI, Paras Hospital, Manipal Hospital, Max Hospital in New Delhi and Gurugram, India.
DR. RITESH SHARMA
- Dr. Ritesh is a senior Consultant Radiation Oncologist at Batra Hospital, Delhi, Dr. Ritesh Sharma.
- He has been trained at Rajiv Gandhi Cancer Institute, Delhi, and Max Cancer Center, Saket.
- 13 years of experience in Radiation Oncology.
- Specializes in SRS/SRT for brain tumors, SBRT for lung, liver, and spine, and hypofractionation for various malignancies.
- Proficient in 4D CT for treating moving tumors and brachytherapy for various cancers.
- Education includes MBBS and MD in Radiotherapy from Gandhi Medical College, Bhopal.
तेजस्वी विश्रांती: ब्लूममध्ये स्तन कर्करोग अभयारण्य- डेकेअर सुविधा
The AOHC Chemotherapy Daycare is unique for integrating a Hyperbaric Oxygen Chamber with chemotherapy, enhancing patient recovery. It also offers additional treatments like IV Vitamin C, promoting a holistic approach to cancer care.
Personalized Chemotherapy through Chemosensitivity / Tumour Viability
- Culturing Cancer Cells: Isolate and grow cancer stem cells in a lab to replicate the tumor environment.
- Drug Exposure: Introduce chemotherapeutic drugs to the cultured cells to test their effectiveness.
- Inhibition Assessment: Measure the drugs’ ability to inhibit cancer cell growth or induce cell death, guiding treatment choices. The results provide valuable insights into which chemotherapeutic agents are likely to be most effective in treating the specific cancer type, potentially guiding personalized treatment plans for patients.
HBOT
- HBOT mitigates tumor hypoxia, reducing cancer progression and resistance by enhancing tissue oxygenation.
- Increased plasma oxygen through HBOT reaches areas typically inaccessible to red blood cells, diminishing cancer cell advantages.
- HBOT, when paired with chemotherapy, boosts treatment efficacy by elevating ROS levels, especially effective if chemotherapy follows HBOT.
IV VITAMIN C
- Our organization administers high-dose IV Vitamin C at our chemo daycare facility, significantly enhancing serum vitamin C levels to target cancer cells effectively.
- By incorporating IV Vitamin C, we potentiate chemotherapy’s effectiveness, leveraging its ability to increase the cytotoxic impact on tumor cells while aiming to reduce treatment side effects.
- This integrated approach, supported by extensive research, underscores our commitment to providing advanced, comprehensive cancer care at our daycare facility.
PUBLICATIONS
Case report on Reversal of Field Cancerization using Nutraceuticals mapped to the aberrant pathways deciphered via NGS analysis of the neoplastic oral mucosa
International journal of Complementary and Internal Medicine
Impact of Slow- Infusion (Metronomic) 2-Deoxy-D-Glucose in Treatment of Refractory Patient of Gliobalstoma Multiforme
COST OF BREAST CANCER TREATMENT
The cost of breast cancer treatment can vary widely based on factors like cancer type and stage, treatments required, healthcare facility, and the choice between private or public healthcare services. Here’s a general breakdown of potential costs:
- Imaging Tests: Costs for mammograms, ultrasounds, and MRIs range from INR 1,500 to INR 15,000, varying by facility and test type.
- Biopsies: Range from INR 5,000 to INR 30,000, depending on procedure complexity and imaging guidance.
- Lumpectomy: Typically costs between INR 50,000 to INR 1,50,000.
- Mastectomy: Ranges from INR 1,00,000 to INR 3,00,000, influenced by reconstruction choices.
- A complete course ranges from INR 1,00,000 to INR 2,50,000, based on session type and number.
- Costs per cycle range from INR 20,000 to INR 2,00,000, with total varying by drugs used and cycle number.
- Monthly costs can be INR 50,000 to over INR 1,00,000, depending on medications.
- Often exceeds INR 1,00,000 per dose, potentially spanning several doses.
- Includes side effect management, physical therapy, counseling, alternative therapies, adding significantly to total cost.
- Regular appointments, tests, and monitoring for recurrence are ongoing costs.
FACTORS INFLUENCING TREATMENT COSTS
Stage of Cancer
Treatment Plan
Personalized Treatment Approaches
आर्ट ऑफ हीलिंग कॅन्सर: ब्रेस्ट कॅन्सर ट्रीटमेंटची पुनर्परिभाषित करणारी पायनियरिंग रोबोटिक इनोव्हेशन
Art of Healing Cancer proudly stands among the first in the nation to offer robotic breast cancer surgery. This advanced technique enhances precision, reduces recovery time, and minimizes scarring, representing a significant leap forward in surgical oncology and patient care.
Dr. Toesca and colleagues from Milan are recognized for their extensive use of robotic assistance in performing skin sparing/nipple sparing surgeries, highlighting its significant benefits:
- Improved Accessibility & Precision: Robotic arms overcome the limitations of traditional retractors, offering better access and angles for surgery. This, combined with enhanced vision, ensures precise dissection.
- Aesthetic Incisions: Strategically placed incisions in less visible areas, such as the axillary or inferior mammary creases, lead to superior aesthetic outcomes.
- Preservation of Skin Flap Vascularity: The technology reduces the need for counter traction and optimizes incision planning, safeguarding skin flap vascularity.
Studies Supporting Robotic Assistance:
- Seiber et al. found that robotic assistance could halve surgical time and eliminate the need for a posterolateral thoracic (back) scar.
- Fourage et al. validated the safety and efficacy of Robot-Assisted LD Flap procedures, emphasizing minimal scarring and precise dissection.
Robot Assisted Functional Breast Preservation Surgery
This cutting-edge approach marries the precision of robotics with the aim of maintaining both the physical and functional aspects of the breasts during cancer treatments. The method excels in removing suspicious tissue while conserving the skin and nipple when feasible, alongside immediate breast reconstruction.
Key Benefits:
- Non-Invasive Access: Entry through the axilla avoids back incisions and scars, eliminating the need for patient repositioning.
- Surgical Efficiency: The combination of a 3D magnified view, enhanced ergonomics, and the dexterity of robotic arms simplifies the procedure, making it more efficient.
ब्रेस्ट कॅन्सर केअर पद्धतीचा डायनॅमिक ॲप्रोच
Breast cancer, a complex disease, starts with uncontrolled cell growth in the breast, forming tumors detectable by lumps or X-rays. It can metastasize, spreading to other body parts. This spectrum of diseases varies in behavior, treatment response, and outcome.
The most common type, IDC, begins in milk ducts, invading surrounding tissues and potentially spreading further. Treatment usually involves surgery, radiation, chemotherapy, and hormone therapy.
Starting in milk-producing lobules, ILC, accounting for 10% of cases, may be hard to detect. Treatment is similar to IDC but tailored to tumor specifics.
A non-invasive, ‘pre-cancer’ form in a breast duct, DCIS heightens invasive cancer risk. Management focuses on prevention, often involving surgery and possibly radiation.
Aggressive and lacking three common receptors, TNBC primarily relies on chemotherapy. It’s prevalent in younger women and BRCA1 gene mutation carriers.
Characterized by excessive HER2 protein, this aggressive form responds to targeted therapies like trastuzumab, significantly improving outcomes.
Indicating higher invasive cancer risk, LCIS, found in lobules, typically involves monitoring and preventive strategies, occasionally requiring medication or surgery.
Testing and Screening for Breast Cancer
In the realm of breast cancer detection, various screening and diagnostic tools are employed to uncover and understand the nature of the disease:
The cornerstone of breast cancer screening, this X-ray tool is pivotal for both routine checks in asymptomatic women and in cases where cancer is suspected.
Employing sound waves, ultrasounds are instrumental in differentiating between solid masses (potential cancers) and fluid-filled cysts.
For high-risk patients or ambiguous cases, an MRI provides detailed breast imaging, crucial for comprehensive assessment.
The definitive diagnostic approach involves extracting tissue samples for lab analysis. Various techniques like fine-needle aspiration and surgical biopsy cater to different situations.
A clinical examination by a healthcare provider, detecting lumps or changes in the breast and underarm areas.
Post-diagnosis, tools like bone scans, CT, or PET scans are employed to explore if cancer has spread beyond the breast and lymph nodes.
For those with a family history, tests can reveal mutations in genes like BRCA1 and BRCA2, informing risk and guiding prevention strategies.
Determines if cancer growth is driven by hormones, impacting treatment plans.
Identifies overproduction of HER2 protein in cancer cells, essential for targeting specific treatments.
Causes and Risk Factors of Breast Cancer
Mutations in genes like BRCA1 and BRCA2 significantly raise breast cancer risk, necessitating vigilant monitoring and preventive strategies.
Extended exposure to hormones, especially estrogen and progesterone, linked to early menstruation or late menopause, increases risk.
Factors like alcohol consumption, obesity, lack of physical activity, and exposure to radiation or carcinogens elevate risk.
Late or no childbirth, not breastfeeding, and certain birth control types can slightly increase breast cancer risk.
Risk increases with age, predominantly affecting women over 50; men, while less commonly, are also at risk.
A first-degree relative with breast cancer doubles the risk; certain inherited conditions also play a role.
Past breast cancer or certain non-cancerous breast diseases can increase the likelihood of developing breast cancer again.
Denser breasts, with more connective and glandular tissue, can make detection harder and independently raise breast cancer risk.
Symptoms of Breast Cancer
A new lump in the breast or underarm, possibly hard with uneven edges or soft and tender, should prompt a doctor’s visit.
Noticeable alterations in the breast’s size, shape, or appearance, like swelling or shrinkage, especially on one side.
Puckering, dimpling, redness, or flaky, scaly skin, particularly around the nipple, can indicate breast cancer.
Inversion, scaliness, redness, or swelling of the nipple, along with texture changes in the areola.
Unexplained discharge, especially clear or bloody and unrelated to breastfeeding, necessitates medical evaluation.
Persistent breast or armpit pain, especially if localized and unrelated to the menstrual cycle, needs assessment.
Swelling in the breast or underarm, possibly with tenderness, even without a detectable lump.
Swollen lymph nodes under the arm or around the collarbone can be an early sign of breast cancer, sometimes occurring before a breast lump is felt.
Stages of Breast Cancer
The earliest stage where cancer cells are confined within breast ducts. Treatment typically involves surgery and possibly radiation.
- IA: Tumor measures up to 2 cm, hasn’t spread outside the breast.
- IB: Small cancer clusters up to 2 mm in lymph nodes, or a tumor in the breast up to 2 cm.
- IIA: Tumor 2-5 cm or cancer in 1-3 axillary lymph nodes.
- IIB: Tumor larger than 5 cm without lymph node spread, or 2-5 cm with 1-3 node involvement.
Advanced stage with large tumor size or extensive lymph node involvement, but no distant spread. Subdivided into IIIA, IIIB, and IIIC, based on tumor size and extent of spread.
Cancer has spread beyond the breast to distant organs. Treatment focuses on managing disease and improving quality of life with systemic therapies.
Cancer returns after initial treatment, varying from local to distant recurrence. Treatment is personalized based on recurrence location and previous treatments.
ब्रेस्ट ट्यूमर मॅस्ट्री- इंटिग्रेटिव्ह ऑन्कोलॉजीसाठी सामंजस्यपूर्ण उपचारांचा दृष्टीकोन
Administering high-dose Vitamin C intravenously, this therapy is explored for its potential to produce hydrogen peroxide, which may target cancer cells, enhance life quality, and mitigate side effects of traditional treatments.
An innovative therapy where patients inhale molecular hydrogen gas, leveraging its antioxidant properties to potentially reduce oxidative stress in cancer cells. Its efficacy and safety in humans are subjects of ongoing research.
Involves breathing pure oxygen in a pressurized environment, believed to enhance tissue oxygenation and aid healing. Used cautiously in cancer care to potentially improve chemotherapy and radiation effectiveness and manage side effects.
Utilizes extracts from the European mistletoe plant, injected to possibly stimulate the immune system and exert cytotoxic effects on cancer cells. While popular in Europe for quality of life improvement, its scientific validation remains mixed.
An ancient Indian practice focusing on body system balance through diet, herbal treatment, and yogic breathing. Aimed at detoxification, boosting defense mechanisms, and overall well-being, it complements conventional treatments despite limited clinical trial evidence.
Treatment Options for Breast Cancer
A critical component in breast cancer management, aiming to remove cancer and assess its extent.
- Lumpectomy: Removes the tumor and a margin of healthy tissue, preserving the breast. Usually followed by radiation.
- Mastectomy: Entire breast removal. Variants include simple, total, double, skin-sparing, and nipple-sparing mastectomies, depending on the extent and patient preference.
- Sentinel Node Biopsy: Removes initial lymph nodes receiving drainage from the tumor to check for cancer spread.
- Axillary Lymph Node Dissection: Removes additional lymph nodes if cancer is found in sentinel nodes.
- Breast Reconstruction: Can be immediate or delayed, using implants or autologous tissue.
Uses cytotoxic drugs to target rapidly dividing cancer cells, administered intravenously, orally, or by injection. Types include Anthracyclines, Taxanes, Alkylating Agents, and Antimetabolites. Can be neoadjuvant (before surgery), adjuvant (after surgery), or palliative.
Focuses on specific genes or proteins involved in cancer growth.
- Monoclonal Antibodies: Bind to cancer cell molecules, blocking growth or aiding immune response.
- Tyrosine Kinase Inhibitors: Block enzymes promoting cancer cell growth.
- Proteasome Inhibitors: Hinder protein breakdown needed for cancer cell survival.
- Histone Deacetylase Inhibitors: Affect gene expression regulation in cancer cells.
Enhances the body’s immune response against cancer.
- Checkpoint Inhibitors: Unblock immune cells to attack cancer.
- Monoclonal Antibodies: Target specific cancer cells.
- Cancer Vaccines: Train the immune system to recognize cancer cells.
- Adoptive Cell Therapy: Modifies patient’s immune cells to better fight cancer.
- Oncolytic Virus Therapy: Uses viruses to target and destroy cancer cells.
Uses high-energy beams to kill or halt cancer cell growth.
- External Beam Radiation Therapy (EBRT): Directs radiation from outside the body.
- Internal Radiation Therapy (Brachytherapy): Places radioactive material near cancer cells.
- Systemic Radiation Therapy: Uses radioactive substances in the blood.
- Proton Therapy: Utilizes protons for precise targeting.
Customizes treatment based on genetic profiling of cancer.
Genomic Sequencing (NGS): Identifies specific mutations for targeted therapies.
Chemosensitivity: Tests cancer cell response to chemotherapy drugs.
RNA Sequencing: Analyzes gene expression for targeted interventions.
Tissue Banking: Stores samples for future research.
Circulating Tumor Cell (CTC): Monitors disease progression through blood analysis.
Metabolic Therapy: Targets cancer cell metabolism through dietary changes.
Complementary approaches focusing on well-being and symptom management.
- Diet and Nutrition: Emphasizes whole foods and anti-inflammatory items.
- Herbal Supplements: Includes evidence-based herbs for cancer care or symptom relief.
- Mind-Body Therapies: Practices like meditation, yoga, and tai chi for stress reduction.
- IV Vitamin C: High-dose therapy with potential benefits but not widely accepted.
- Hydrogen Inhalation Therapy: Emerging approach with antioxidant properties.
- Hyperbaric Oxygen Therapy (HBOT): Enhances chemotherapy and radiation efficacy, with cautious use.
- Mistletoe Therapy: Used for immune stimulation and quality of life improvement.
- Ayurvedic Medicine: Focuses on holistic care, often alongside conventional treatments.
Each treatment option is chosen based on individual patient factors, cancer stage, and overall health, offering a comprehensive approach to breast cancer management.
